Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS1 | P09382 | 2/20 | 0.44 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.44 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.44 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 3/20 | 0.36 |
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA9 | Q16790 | 3/20 | 0.36 |
| ▸ | PYGB | P11216 | 6/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9231902 | 1.00 | LGALS1 (0.44) | LGALS1LGALS3LGALS9LGALS8ALDH1A1 | |
| SCHEMBL30854796 | 0.94 | LGALS1 (0.45) | LGALS1LGALS3LGALS9LGALS8ALDH1A1 | |
| SCHEMBL7117447 | 0.91 | CYP2C19 (0.41) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| SCHEMBL1259745 | 0.91 | CYP2C19 (0.41) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| SCHEMBL28456180 | 0.91 | CYP2C19 (0.41) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| SCHEMBL31121686 | 0.91 | CYP2C19 (0.41) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| SCHEMBL1600427 | 0.91 | CYP2C19 (0.41) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| SCHEMBL1259125 | 0.91 | CYP2C19 (0.41) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| SCHEMBL1259123 | 0.91 | CYP2C19 (0.41) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| SCHEMBL1259494 | 0.91 | CYP2C19 (0.41) | LGALS1LGALS3LGALS9LGALS8LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8987216-B2 | Polysulfated glycosides and salts thereof | Teva Hungary Pharmaceutical Marketing Private Limited Company (HU) | 2015-03-24 | — | — | US | disclosed |
| US-20110118198-A1 | POLYSULFATED GLYCOSIDES AND SALTS THEREOF | IVAX DRUG RESEARCH INSTITUTE LTD. (HU) | 2011-05-19 | — | — | US | disclosed |
| US-7902158-B2 | Polysulfated glycosides and salts thereof | Ivax Drug Research Ltd. (HU) | 2011-03-08 | — | — | US | disclosed |
| EP-1778709-B1 | POLYSULFATED GLYCOSIDES AND SALTS THEREOF | IVAX DRUG RES INST LTD (HU) | 2008-05-28 | — | — | EP | disclosed |
| US-20070281893-A1 | Polysulfated Glycosides And Salts Thereof | IVAX DRUG RESEARCH INSTITUTE LTD (HU) | 2007-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110118198-A1 | POLYSULFATED GLYCOSIDES AND SALTS THEREOF | CFTR, AREG, STS | LGALS1 72/4885LGALS3 147/4885LGALS9 220/4885 |
| US-20070281893-A1 | Polysulfated Glycosides And Salts Thereof | CFTR, AREG, STS | LGALS1 72/4885LGALS3 147/4885LGALS9 220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.